Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ruinian International, also known as RealNutriceutical Group, is a Chinese healthcare company that specialized in the production and sale of amino acid-based nutritional supplements and pharmaceutical products. The company's pharmaceutical operations were primarily conducted through its subsidiary, Nanjing Ruinian Best Pharmaceutical, which manufactured a range of generic drugs for cardiovascular and digestive health. Ruinian was once a leader in the Chinese health supplement market, with its "Best" brand of amino acid oral liquids being a flagship product. However, the company was embroiled in financial scandals and allegations of inflated revenue, leading to a suspension of its shares and eventual delisting from the Hong Kong Stock Exchange in 2020. The company is currently considered inactive as it undergoes liquidation proceedings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RuiNian Best Company.